UK markets closed

Molecular Partners AG (MOLN)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
6.35+0.50 (+8.56%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
6,726
7,038
189,556
9,330
9,344
-
Operating expenses
Research development
50,193
48,784
50,749
55,718
56,075
-
Selling general and administrative
18,044
18,995
21,822
16,906
11,027
-
Total operating expenses
68,604
68,146
72,943
72,749
67,670
-
Operating income or loss
-61,878
-61,108
116,613
-63,419
-58,326
-
Interest expense
32
34
605
548
295
-
Total other income/expenses net
-1,120
-5,106
717
92
-4,512
-
Income before tax
-58,531
-61,984
117,853
-63,783
-62,775
-
Income tax expense
0
0
0
2
-11
-
Income from continuing operations
-58,531
-61,984
117,853
-63,785
-62,764
-
Net income
-58,531
-61,984
117,853
-63,785
-62,764
-
Net income available to common shareholders
-58,531
-61,984
117,853
-63,785
-62,764
-
Basic EPS
-1.83
-
3.63
-2.06
-2.51
-1.69
Diluted EPS
-1.83
-
3.54
-2.06
-2.51
-1.69
Basic average shares
32,693
-
32,470
31,005
25,001
21,413
Diluted average shares
32,942
-
33,266
31,005
25,001
21,413